Simulations Plus Inc (SLP)

15.10
0.15 0.98
NASDAQ : Technology
Prev Close 15.25
Open 15.25
Day Low/High 14.75 / 15.30
52 Wk Low/High 6.08 / 11.89
Volume 23.84K
Avg Volume 88.10K
Exchange NASDAQ
Shares Outstanding 17.25M
Market Cap 257.82M
EPS 0.30
P/E Ratio 46.72
Div & Yield 0.20 (1.30%)

Latest News

DILIsym Services Inc., A Simulations Plus Company, Releases DILIsym® Version 6A

DILIsym Services Inc., A Simulations Plus Company, Releases DILIsym® Version 6A

DILIsym Services Inc., a Simulations Plus company (NASDAQ: SLP) and a leading provider of simulation and modeling software for pharmaceutical safety and efficacy, today announced that it has released Version 6A of its...

SLP Ex-Dividend Reminder - 7/26/17

Looking at the universe of stocks we cover at Dividend Channel, on 7/26/17, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.05, payable on 8/4/17.

Market Can't Sustain Upside Push

Market Can't Sustain Upside Push

Catching a decent wave more about luck than skill.

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals industries, today announced that its board of...

Simulations Plus Reports Third Quarter FY2017 Financial Results

Simulations Plus Reports Third Quarter FY2017 Financial Results

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical...

Simulations Plus Sets Date For 3rd Quarter 2017 Earnings Release And Conference Call

Simulations Plus Sets Date For 3rd Quarter 2017 Earnings Release And Conference Call

Simulations Plus, Inc. (Nasdaq:SLP) announced today that it expects to file its quarterly report on Form 10-Q for the third quarter of its 2017 fiscal year, the period ended May 31, 2017, on Monday, July 10, 2017.

Simulations Plus Reports Record Preliminary Revenues For Third Quarter FY2017

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the third quarter of its fiscal year 2017,...

Simulations Plus Closes Acquisition Of DILIsym Services, Inc.

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that the Stock Purchase Agreement (the "Agreement") with DILIsym...

Simulations Plus To Present At The 7th Annual LD Micro Invitational

Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, announced that it will be presenting at the 7 th Annual LD...

Simulations Plus To Present At The Needham Emerging Technology Conference

Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical...

Simulations Plus About To Put More Money In Your Pocket (SLP)

Looking at the universe of stocks we cover at Dividend Channel, on 5/4/17, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.05, payable on 5/15/17.

Simulations Plus To Acquire DILIsym Services, Inc.

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it has entered into a Stock Purchase Agreement (the...

Dr. Daniel Weiner Joins Simulations Plus Board Of Directors

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that Dr.

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals industries, today announced that its board of...

Simulations Plus Establishes Distribution Channel In India With Electrolab

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals industries, today announced that it has signed a...

Simulations Plus Reports Second Quarter FY2017 Financial Results

Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for all phases of pharmaceutical discovery and development from the earliest discovery through all...

Simulations Plus Finalizes Distributor Agreement With Korean Company

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling & simulation solutions for the pharmaceutical, biotechnology, and chemicals industries, today announced that it has entered into a distributor...

Simulations Plus Releases GastroPlus™ Version 9.5

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling & simulation solutions for the pharmaceutical, biotechnology, and chemicals industries, today announced that it has released version 9.

Simulations Plus Sets Date For 2nd Quarter 2017 Earnings Release And Conference Call

Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on Form 10-Q for the second quarter of its 2017 fiscal year on Monday, April 10, 2017.

Simulations Plus Reports Record Preliminary Revenues For Second Quarter FY2017

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the second quarter of its fiscal year 2017,...

SLP Ex-Dividend Reminder - 1/26/17

SLP Ex-Dividend Reminder - 1/26/17

Looking at the universe of stocks we cover at Dividend Channel, on 1/26/17, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.05, payable on 2/6/17.

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has declared its next ongoing quarterly...

Simulations Plus Releases ADMET Predictor™ Version 8.1

Simulations Plus Releases ADMET Predictor™ Version 8.1

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that it has released Version 8.

Simulations Plus Reports First Quarter FY2017 Financial Results

Simulations Plus Reports First Quarter FY2017 Financial Results

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all stages of pharmaceutical discovery and development from the earliest discovery through all...

Simulations Plus Sets Date For 1st Quarter 2017 Earnings Release And Conference Call

Simulations Plus Sets Date For 1st Quarter 2017 Earnings Release And Conference Call

Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on Form 10-Q for the first quarter of its 2017 fiscal year on Monday, January 9, 2017.

Simulations Plus Reports Record Preliminary Revenues For First Quarter FY2017

Simulations Plus Reports Record Preliminary Revenues For First Quarter FY2017

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the first quarter of its fiscal year 2017,...

Simulations Plus Reports FY2016 And Fourth Quarter FY2016 Financial Results

Simulations Plus Reports FY2016 And Fourth Quarter FY2016 Financial Results

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2016 fiscal year (FY16) and fourth quarter (4Q16) ended August...

Simulations Plus Sets Date For 4th Quarter And Fiscal Year 2016 Earnings Release And Conference Call

Simulations Plus Sets Date For 4th Quarter And Fiscal Year 2016 Earnings Release And Conference Call

Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file Form 10-K for the 2016 fiscal year ended August 31, 2016, with the U.

TheStreet Quant Rating: A- (Buy)